{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:48:25Z","timestamp":1791510505452,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"am","delay-in-days":318,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.bmcl.2021.128171","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T11:42:24Z","timestamp":1623757344000},"page":"128171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Synthesis and biological activity of conformationally restricted indole-based inhibitors of neurotropic alphavirus replication: Generation of a three-dimensional pharmacophore"],"prefix":"10.1016","volume":"46","author":[{"given":"Scott J.","family":"Barraza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice A.","family":"Sindac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"Dobry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip C.","family":"Delekta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pil H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2021.128171_b0005","doi-asserted-by":"crossref","first-page":"104875","DOI":"10.1016\/j.antiviral.2020.104875","article-title":"Comparative pathology study of Venezuelan, eastern, and western equine encephalitis viruses in non-human primates","volume":"182","author":"Smith","year":"2020","journal-title":"Antiviral Res"},{"issue":"3-4","key":"10.1016\/j.bmcl.2021.128171_b0010","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.vetmic.2009.08.023","article-title":"Encephalitic alphaviruses","volume":"140","author":"Zacks","year":"2010","journal-title":"Vet Microbiol"},{"issue":"15","key":"10.1016\/j.bmcl.2021.128171_b0015","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM195710102571504","article-title":"Equine Encephalitis in Massachusetts","volume":"257","author":"Feemster","year":"1957","journal-title":"New Engl J Med"},{"issue":"26","key":"10.1016\/j.bmcl.2021.128171_b0020","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1056\/NEJM199706263362604","article-title":"Clinical and neuroradiographic manifestations of Eastern equine encephalitis","volume":"336","author":"Deresiewicz","year":"1997","journal-title":"New Engl J Med"},{"key":"10.1016\/j.bmcl.2021.128171_b0025","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41531-019-0090-8","article-title":"Infection with mosquito-borne alphavirus induces selective loss of dopaminergic neurons, neuroinflammation and widespread protein aggregation","volume":"5","author":"Bantle","year":"2019","journal-title":"NPJ Parkinsons Dis"},{"issue":"4","key":"10.1016\/j.bmcl.2021.128171_b0030","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1086\/513978","article-title":"Epidemic Venezuelan equine encephalitis in La Guajira, Colombia, 1995","volume":"175","author":"Rivas","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bmcl.2021.128171_b0035","doi-asserted-by":"crossref","unstructured":"Ehrenkranz, N. J.; Ventura, A. K., Venezuelan Equine Encephalitis Virus Infection in Man. 1974, 9-14.","DOI":"10.1146\/annurev.me.25.020174.000301"},{"key":"10.1016\/j.bmcl.2021.128171_b0040","series-title":"Neurotropic Viral Infections","first-page":"94","author":"Griffin","year":"2008"},{"key":"10.1016\/j.bmcl.2021.128171_b0045","unstructured":"Steele, K. E. R., D.S.; Glass, P.J.; Hart, M.K.; Ludwig, G.V.; Pratt, W.D.; Parker, M.D.; Smith, J.F., Alphavirus Encephalitides. In Medical Aspects of Biological Warfare, Dembek, Z. F., Ed. Office of the Surgeon General: United States of America, 2007; pp 241-270."},{"key":"10.1016\/j.bmcl.2021.128171_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/8521060","volume":"2018","author":"Dupuy","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.bmcl.2021.128171_b0055","doi-asserted-by":"crossref","unstructured":"C.W. Burke J.W. Froude S. Miethe B. Hulseweh M. Hust P.J. Glass Human-Like Neutralizing Antibodies Protect Mice from Aerosol Exposure with Western Equine Encephalitis Virus Viruses 10 4 2018 147\/1-147\/7.","DOI":"10.3390\/v10040147"},{"key":"10.1016\/j.bmcl.2021.128171_b0060","doi-asserted-by":"crossref","unstructured":"S.-Y. Ko W. Akahata E.S. Yang et al. A virus-like particle vaccine prevents equine encephalitis virus infection in nonhuman primates Sci Transl Med 11 492 2019 eaav3113 10.1126\/scitranslmed.aav3113.","DOI":"10.1126\/scitranslmed.aav3113"},{"issue":"2","key":"10.1016\/j.bmcl.2021.128171_b0065","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/vaccines8020273","article-title":"Vaccine Advances against Venezuelan, Eastern, and Western Equine Encephalitis Viruses","volume":"8","author":"Stromberg","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"3","key":"10.1016\/j.bmcl.2021.128171_b0070","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.antiviral.2011.09.012","article-title":"Brain distribution of ribavirin after intranasal administration","volume":"92","author":"Colombo","year":"2011","journal-title":"Antiviral Res"},{"issue":"8","key":"10.1016\/j.bmcl.2021.128171_b0075","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1517\/14656566.2.8.1317","article-title":"Ribavirin - current status of a broad spectrum antiviral agent","volume":"2","author":"Snell","year":"2001","journal-title":"Expert Opin Pharmacother"},{"issue":"Suppl 4","key":"10.1016\/j.bmcl.2021.128171_b0080","doi-asserted-by":"crossref","first-page":"S750","DOI":"10.1093\/clinids\/11.Supplement_4.S750","article-title":"Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug","volume":"11","author":"Huggins","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"4","key":"10.1016\/j.bmcl.2021.128171_b0085","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1089\/bsp.2009.0032","article-title":"Alphavirus antiviral drug development: scientific gap analysis and prospective research areas","volume":"7","author":"Reichert","year":"2009","journal-title":"Biosecur Bioterror"},{"key":"10.1016\/j.bmcl.2021.128171_b0090","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.antiviral.2014.10.002","article-title":"Small molecule inhibitors of Ago2 decrease Venezuelan equine encephalitis virus replication","volume":"112","author":"Madsen","year":"2014","journal-title":"Antiviral Res"},{"issue":"12","key":"10.1016\/j.bmcl.2021.128171_b0095","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1021\/acsinfecdis.9b00035","article-title":"Studies on Dibenzylamines as Inhibitors of Venezuelan Equine Encephalitis Virus","volume":"5","author":"Nguyen","year":"2019","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmcl.2021.128171_b0100","doi-asserted-by":"crossref","first-page":"104854","DOI":"10.1016\/j.antiviral.2020.104854","article-title":"A small molecule inhibitor of MyD88 exhibits broad spectrum antiviral activity by up regulation of type I interferon","volume":"181","author":"Saikh","year":"2020","journal-title":"Antiviral Res"},{"issue":"5","key":"10.1016\/j.bmcl.2021.128171_b0105","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1177\/1087057114564868","article-title":"The combined use of alphavirus replicons and pseudoinfectious particles for the discovery of antivirals derived from natural products","volume":"20","author":"Delekta","year":"2015","journal-title":"J Biomol Screen"},{"issue":"5","key":"10.1016\/j.bmcl.2021.128171_b0110","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bjp.2016.05.004","article-title":"Potent inhibition of Western Equine Encephalitis virus by a fraction rich in flavonoids and phenolic acids obtained from Achyrocline satureioides","volume":"26","author":"Sabini","year":"2016","journal-title":"Revista Brasileira de Farmacognosia"},{"issue":"7","key":"10.1016\/j.bmcl.2021.128171_b0115","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/597275","article-title":"Identification of thieno[3,2-b]pyrrole derivatives as novel small molecule inhibitors of neurotropic alphaviruses","volume":"199","author":"Peng","year":"2009","journal-title":"J Infect Dis"},{"issue":"22","key":"10.1016\/j.bmcl.2021.128171_b0120","doi-asserted-by":"crossref","first-page":"9222","DOI":"10.1021\/jm401330r","article-title":"Optimization of Novel Indole-2-carboxamide Inhibitors of Neurotropic Alphavirus Replication","volume":"56","author":"Sindac","year":"2013","journal-title":"J Med Chem"},{"issue":"7","key":"10.1016\/j.bmcl.2021.128171_b0125","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1021\/jm300214e","article-title":"Novel Inhibitors of Neurotropic Alphavirus Replication That Improve Host Survival in a Mouse Model of Acute Viral Encephalitis","volume":"55","author":"Sindac","year":"2012","journal-title":"J Med Chem"},{"issue":"7","key":"10.1016\/j.bmcl.2021.128171_b0130","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.bmc.2015.01.054","article-title":"Discovery of anthranilamides as a novel class of inhibitors of neurotropic alphavirus replication","volume":"23","author":"Barraza","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2021.128171_b0135","unstructured":"Lemke, T. L. W., D.A., Foye's Principles of Medicinal Chemistry. Sixth ed.; Lippincott Williams and Wilkinds: USA, 2008."},{"issue":"3","key":"10.1016\/j.bmcl.2021.128171_b0140","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cbpa.2008.03.009","article-title":"Peptidomimetics, a synthetic tool of drug discovery","volume":"12","author":"Vagner","year":"2008","journal-title":"Curr Opin Chem Biol"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128171_b0145","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/0929867053363540","article-title":"Bioisosterism: A useful strategy for molecular modification and drug design","volume":"12","author":"Lima","year":"2005","journal-title":"Curr Med Chem"},{"issue":"4","key":"10.1016\/j.bmcl.2021.128171_b0150","first-page":"471","article-title":"The use of bioisosteric groups in lead optimization","volume":"4","author":"Olesen","year":"2001","journal-title":"Curr Opin Drug Discov Devel"},{"issue":"3","key":"10.1016\/j.bmcl.2021.128171_b0155","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1020155510718","article-title":"A review of protein-small molecule docking methods","volume":"16","author":"Taylor","year":"2002","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.bmcl.2021.128171_b0160","unstructured":"Wermuth, C. G. M., A., The Practice of Medicinal Chemistry. Second ed.; Wermuth, C. G., Ed. Elsevier Inc.: USA, 2003."},{"issue":"2","key":"10.1016\/j.bmcl.2021.128171_b0165","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0022-3565(24)29396-4","article-title":"Competitive Neuronal Nicotinic Receptor Antagonists: A New Direction for Drug Discovery","volume":"298","author":"Dwoskin","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"10.1016\/j.bmcl.2021.128171_b0170","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1021\/jm020415q","article-title":"Cyclopropane-Based Conformational Restriction of Histamine. (1S,2S)-2-(2-Aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a Highly Selective Agonist for the Histamine H3 Receptor, Having a cis-Cyclopropane Structure","volume":"46","author":"Kazuta","year":"2003","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.bmcl.2021.128171_b0175","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/0041-008X(90)90233-K","article-title":"Structure-activity relationships of retinoids in developmental toxicology: IV. Planar cisoid conformational restriction","volume":"103","author":"Willhite","year":"1990","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.bmcl.2021.128171_b0180","unstructured":"Larsen, S.; Sindac, J.; Barraza, S.; Miller David, J. Arbovirus Inhibitors And Uses Thereof. US 2012\/0252807 A1, 2012\/03\/19, 2012."},{"issue":"2","key":"10.1016\/j.bmcl.2021.128171_b0185","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00726-009-0467-9","article-title":"Synthesis of 2-azaspiro[3.3]heptane-derived amino acids: ornitine and GABA analogues","volume":"39","author":"Radchenko","year":"2010","journal-title":"Amino Acids"},{"issue":"17","key":"10.1016\/j.bmcl.2021.128171_b0190","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1021\/jo101271h","article-title":"Cyclobutane-Derived Diamines: Synthesis and Molecular Structure","volume":"75","author":"Radchenko","year":"2010","journal-title":"J Organ Chem"},{"issue":"6","key":"10.1016\/j.bmcl.2021.128171_b0195","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1021\/jo01017a057","article-title":"Conformational Analysis. XLIII. Stereochemical Studies in the Cyclobutane Ring System1-3","volume":"30","author":"Allinger","year":"1965","journal-title":"J Organ Chem"},{"issue":"7","key":"10.1016\/j.bmcl.2021.128171_b0200","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1021\/jo00086a005","article-title":"Deprotection of Arenesulfonamides with Samarium iodide","volume":"59","author":"Vedejs","year":"1994","journal-title":"J Organ Chem"},{"issue":"3","key":"10.1016\/j.bmcl.2021.128171_b0205","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1021\/ol802243d","article-title":"Instantaneous Deprotection of Tosylamides and Esters with SmI2\/Amine\/Water","volume":"11","author":"Ankner","year":"2009","journal-title":"Org Lett"},{"issue":"8","key":"10.1016\/j.bmcl.2021.128171_b0210","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0040-4039(98)02646-X","article-title":"Deprotection of sulfonamides using iodotrimethylsilane","volume":"40","author":"Sabitha","year":"1999","journal-title":"Tetrahedron Lett"},{"issue":"42","key":"10.1016\/j.bmcl.2021.128171_b0215","doi-asserted-by":"crossref","first-page":"14417","DOI":"10.1016\/S0040-4020(97)00935-6","article-title":"A new synthetic approach to the polyoxins: Concise stereoselective preparation of protected thymine polyoxin C","volume":"53","author":"Gethin","year":"1997","journal-title":"Tetrahedron"},{"issue":"2","key":"10.1016\/j.bmcl.2021.128171_b0220","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/chem.200390061","article-title":"Sequestered Alkyllithiums: Why Phenyllithium Alone is Suitable for Betaine-Ylide Generation. Chemistry \u2013 A","volume":"9","author":"Wang","year":"2003","journal-title":"European Journal"},{"issue":"9","key":"10.1016\/j.bmcl.2021.128171_b0225","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/cber.19941270918","article-title":"Pyridinio-isoalloxazinophanes as Model Systems for Active-Site Complexes in Flavoenzymes: Syntheses, X-Ray Structure Analyses and Spectroscopic Properties","volume":"127","author":"Staab","year":"1994","journal-title":"Chemische Berichte"},{"issue":"4","key":"10.1016\/j.bmcl.2021.128171_b0230","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1021\/cr00094a007","article-title":"The Wittig olefination reaction and modifications involving phosphoryl-stabilized carbanions. Stereochemistry, mechanism, and selected synthetic aspects","volume":"89","author":"Maryanoff","year":"1989","journal-title":"Chem Rev"},{"issue":"12","key":"10.1016\/j.bmcl.2021.128171_b0235","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/cbic.201100272","article-title":"An evaluation of peptide-bond isosteres","volume":"12","author":"Choudhary","year":"2011","journal-title":"ChemBioChem"},{"issue":"13-14","key":"10.1016\/j.bmcl.2021.128171_b0240","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.drudis.2009.04.003","article-title":"Navigating structure-activity landscapes","volume":"14","author":"Bajorath","year":"2009","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmcl.2021.128171_b0245","unstructured":"DataWarrior v05.02.01. http:\/\/www.openmolecules.org\/index.html."},{"issue":"3","key":"10.1016\/j.bmcl.2021.128171_b0250","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1021\/ci7004093","article-title":"Structure\u2013activity landscape index: identifying and quantifying activity cliffs","volume":"48","author":"Guha","year":"2008","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmcl.2021.128171_b0255","unstructured":"Molecular Operating Environment (MOE), 2019.0102; Chemical Computing Group ULC, 1010 Sherbrooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7, 2020."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2100398X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2100398X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:41:20Z","timestamp":1760773280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X2100398X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":51,"alternative-id":["S0960894X2100398X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128171","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological activity of conformationally restricted indole-based inhibitors of neurotropic alphavirus replication: Generation of a three-dimensional pharmacophore","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128171"}}